Seeking Alpha

MissionIR's  Instablog

MissionIR
Send Message
We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices. It is our unwavering commitment to connect the investment community with companies that have great potential and a strong dedication to... More
My company:
MissionIR
My blog:
MissionIR Blog
  • Delcath Systems, Inc. (DCTH) Bolsters Global Marketing Team With Strategic Pharma Oncology Hire 0 comments
    Mar 27, 2012 2:46 PM | about stocks: DCTH

    Delcath Systems announced the appointment of Jennifer Simpson, Ph.D., M.S.N., C.R.N.P., to the position of Executive Vice President, Global Marketing. Ms. Simpson will use her extensive pharmaceutical and oncology marketing background to lead Delcath's global product marketing, brand management and reimbursement programs in the European Union, United States, and other key markets. In line with Ms. Simpson's appointment, Agustin Gago, Delcath's Executive Vice President for Global Sales & Marketing since 2009, will assume the new role of Executive Vice President, Global Sales. Ms. Simpson and Mr. Gago will both report to Eamonn P. Hobbs, President and CEO of Delcath. Both appointments were effective as of March 23, 2012.

    Ms. Simpson has a wealth of experience in global product development in the oncology sector. Before bringing her talents and knowledge to Delcath, Ms. Simpson served as the Vice President, Global Marketing, Oncology Brand Lead at ImClone Systems, Inc. (a wholly-owned subsidiary of Eli Lilly and Company). As Vice President, she successfully handled all product commercialization activities and launch preparation for one of the late stage assets. During her time at ImClone, Ms. Simpson also excelled in various positions of increasing responsibility including Vice President, Product Champion and the Associate Vice President, Product Champion.

    In addition to her successes at ImClone, Ms. Simpson held multiple leadership positions at Ortho Biotech (now Janssen Biotech), a Pennsylvania-based biotech company that focuses on innovative solutions in immunology, oncology, and nephrology. Before her stint at Ortho Biotech, Ms. Simpson acquired over 10 years of experience as an oncology-nurse practitioner and educator.

    "The appointment of Jennifer Simpson adds significant oncology expertise and leadership to our marketing team," said Mr. Hobbs, President and CEO of Delcath. "Over the last year, we've made a concerted effort to build our talent base in order to drive the launch of our CHEMOSAT system. Jennifer's extensive experience in cancer treatment as a nurse, educator, marketer and strategic planner, combined with an intimate knowledge of the commercialization process makes her an ideal fit. We're confident that she will help us realize the full global market potential of CHEMOSAT."

    "The planned transition of Mr. Gago to the position of Executive Vice President, Global Sales will allow him to fully devote his energies to the execution of our global commercial sales strategy. Through Mr. Gago's sales leadership, we are successfully implementing our launch plan for CHEMOSAT in the EU, and will continue to expand the opportunity for CHEMOSAT in new markets around the world."

    Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

    Stocks: DCTH
Back To MissionIR's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers

StockTalks

More »
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.